Skip to main content
. 2020 Jun 13;22(6):1359–1370. doi: 10.1007/s10098-020-01876-1

Table 9.

Allocation of antivirals for Scenario 1.3

Mild Moderate Critical Total antiviral
No antiviral 700 0 0 NA
Antiviral A 50 0 50 100
Antiviral B 50 150 0 200
Total infected symptomatic 800 150 50